Top Markets
Coin of the day
Heat Biologics, Inc. Heat Biologics, Inc.

Heat Biologics, Inc.

HTBX
주식 순위 #24400
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on... Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.
주가
$2.38
마지막 동기화: 2022-05-03
시가총액
$61.07M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Heat Biologics, Inc. (HTBX)

카테고리

Heat Biologics, Inc. (HTBX)의 주가 이력
최고 종가: $2.38 (2022-05-01 기준)

최저 종가: $660.22 (2013-07-01 기준)
Heat Biologics, Inc.의 주가 이력 (2013 ~ 2026)
연간 주가 성과
연도 성과
2022 -38.25%
2021 -38.90%
2020 95.34%
2019 -61.23%
2018 -69.52%
2017 -58.03%
2016 -61.70%
2015 -42.63%
2014 -45.31%
2013 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH